GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
2,646
Funds Holding Change
+92
Funds Holding Growth
+4%
Value
$534B
Holding in Top 10
659
Top 10 Change
+49
Top 10 Growth
+8%
Value Growth
+10%
New
215
Increased
1,167
Reduced
1,064
Closed
84
Capital Inflow
$26.1B
Capital Outflow
$18.1B
Net Capital Flow
+$8.01B
Capital Flow Change
+$607M
Calls
$6.83B
Puts
$7.48B
Net Calls
-$654M
Put/Call Ratio
1.1